Intracellular potassium stabilizes human ether-à-go-go-related gene channels for export from endoplasmic reticulum

Lu Wang1, Adrienne T Dennis, Phan Trieu

  • 1Rammelkamp Center for Education and Research, MetroHealth Campus, Case Western Reserve University, Cleveland, Ohio 44109, USA.

Molecular Pharmacology
|January 14, 2009
PubMed

Insights

Cardiac glycosides disrupt human ether-à-go-go-related gene (hERG) channel trafficking by inhibiting Na+/K+ pumps, leading to intracellular potassium depletion. This potassium depletion causes a conformational defect in hERG, impairing its cell surface transport.

Area of Science:

  • Cardiology
  • Molecular Pharmacology
  • Cell Biology

Background:

  • Therapeutic compounds can prolong QT interval and cause arrhythmias by disrupting hERG channel trafficking.
  • Cardiac glycosides are a key class of compounds that inhibit hERG trafficking.
  • Previous work linked cardiac glycoside inhibition of hERG trafficking to Na+/K+ pump block.

Purpose of the Study:

  • To elucidate the mechanism coupling Na+/K+ pump inhibition to hERG processing.
  • To investigate the role of intracellular potassium in hERG trafficking.
  • To identify conditions and factors that restore hERG trafficking.

Main Methods:

  • Utilized cardiac glycosides and gramicidin to deplete intracellular potassium in cell models.
  • Assessed hERG trafficking under conditions of potassium depletion and restoration.
  • Investigated the effect of ion permeability, temperature, pharmacological chaperones, and hERG mutations on trafficking.

Main Results:

  • Intracellular potassium depletion, induced by cardiac glycosides or gramicidin, disrupts hERG trafficking.
  • Restoration of hERG trafficking in potassium-depleted cells was achieved by K+ or Rb+ ion permeation, low temperatures, astemizole, or specific hERG mutations.
  • These findings indicate a direct link between intracellular potassium levels and hERG channel conformation.

Conclusions:

  • Cardiac glycosides inhibit hERG trafficking via a mechanism involving intracellular potassium depletion.
  • The study reveals a novel pathway for drug-induced trafficking inhibition mediated by potassium-dependent conformational changes in the hERG channel.
  • Understanding this mechanism is crucial for developing safer therapeutics and managing drug-induced arrhythmias.

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Primary Active Transport01:29

Primary Active Transport

In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction they would not...
Primary Active Transport01:47

Primary Active Transport

In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps that are embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction they...
Ion Channels01:19

Ion Channels

The movement of ions like sodium, potassium, and calcium into and out of the cell is essential to maintain the electrochemical gradient in living cells. The ion channels—a class of membrane transport proteins—help maintain this ionic gradient for the smooth functioning of physiological activities such as maintaining cell size and volume, conducting nerve impulses, and gas and nutrient exchange.
Ion channels are specialized integral membrane proteins on the plasma membrane that allow specific...
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.